ALKS FY 2019 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.2B+7.0% YoY

Gross Profit

$991M84.6% margin

Operating Income

-$175M-15.0% margin

Net Income

-$197M-16.8% margin

EPS (Diluted)

$-1.25

Cash Flow

Operating Cash Flow

$72M

Free Cash Flow

-$19M

Stock-Based Comp.

$101M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$720M

Stockholders' Equity

$1.1B

Cash & Equivalents

$204M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+7.0%
Gross Profit	$991M	$918M	+7.9%
Operating Income	-$175M	-$99M	-77.0%
Net Income	-$197M	-$139M	-41.1%